HALISTER: *CVS TO PAY $1.9B TO BUY, OPERATE TARGET'S PHARMACIES & CLINICS

*CVS TO PAY $1.9B TO BUY, OPERATE TARGET'S PHARMACIES & CLINICS

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
CVS US (CVS Health Corp)
TGT US (Target Corp)

People
Brian Cornell (Target Corp)
Larry Merlo (CVS Health Corp)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283